Drug Profile
Research programme: immunological disorder antibodies - Bristol-Myers Squibb
Alternative Names: anti-CD28; anti-IL6Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Antibodies
- Mechanism of Action CD28 antigen modulators; Interleukin-6 modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Immunological disorders